1. PetVivo.ai launched a video to explain their AI platform simply. 2. The platform connects veterinary practices with pet parents needing care. 3. CEO emphasizes clarity and understanding over technical complexity. 4. Ten specialized AI agents are used to enhance veterinary client acquisition. 5. A freemium model is available, starting with a free tier.
FAQ
Why Bullish?
The innovative communication approach may attract more users, increasing demand and revenue. Similar successful launches in tech often lead to significant stock appreciation.
How important is it?
The clarity and accessibility of the launch could significantly enhance market penetration and brand visibility, thus positively influencing PETV's stock.
Why Short Term?
Immediate interest from pet owners and vets could see quick user growth, impacting revenue promptly. Historically, market reactions to successful product launches are swift.
Revolutionary Veterinary AI Platform Ditches Dense Documentation in Favor of Clear, Engaging Video Walkthrough
MINNEAPOLIS, MN, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PetVivo.ai, the AI powered platform transforming how veterinary practices connect with pet parents, today announced something different: instead of another lengthy press release filled with jargon, they made a video.
"Let's be honest," said John Lai, CEO at PetVivo Holdings (OTCQX:PETV, OTCID: PETVW)). "Most tech launches are too complicated and too long to read. We built something revolutionary, and we wanted to explain it in a way people would actually consume. So we made a video that walks through the entire ecosystem in minutes, not pages."
Show, Don't Tell
The newly released video explainer breaks down PetVivo.ai's complete two sided ecosystem in an engaging, visual format that anyone can understand. No jargon, just clear language explaining how the system works with a visual walkthrough showing the platform in action.
"We're solving a real problem for veterinary practices," continued Lai. "The last thing we wanted was for people to struggle understanding our solution. This video makes it crystal clear: here's what we built, here's how it works, here's why it matters."
What the Video Covers
The comprehensive explainer walks viewers through the two sided ecosystem, showing how PetVivo.ai connects pet parents who need veterinary care with veterinary practices who need clients. It explains all 10 specialized AI agents, from Behavioral Scientists to Radiologists, and demonstrates the complete user journey for both pet parents and veterinarians.
A Refreshing Approach
In an industry cluttered with buzzwords and technical complexity, PetVivo.ai's decision to lead with clarity represents a shift in how technology companies communicate.
"We're not trying to sound smart," said Lai. "We're trying to be understood. There's a difference."
The video is now live and available to anyone interested in understanding how AI is transforming veterinary client acquisition.
Watch the Full Explainer
The complete "How PetVivo.ai Works" video is available at https://youtu.be/zlvOjsSbErM and petvivo.ai.
For more information:
Video: https://youtu.be/zlvOjsSbErM
Website: https://petvivo.ai
Investor Relations: investors.petvivo.ai
Stock Symbol: OTCQX: PETV; OTCID: PETVW
About PetVivo.ai
PetVivo.ai is an AI powered platform that connects veterinary practices with engaged pet parents through a revolutionary two sided ecosystem. The system uses 10 specialized AI agents to transform how practices discover and connect with clients while providing pet parents with advanced health tracking tools. The platform offers a freemium model starting with a completely free tier.
About PetVivo Holdings, Inc.
PetVivo Holdings Inc. (OTCQX:PETV, OTCID: PETVW)), in cooperation with its wholly owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI Inc., is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.
PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of twelve patents and six trade secrets protect the Company's biomaterials, products, production processes and methods of use. The Company's lead products SPRYNG® with OsteoCushion® technology, a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses, and PrecisePRP®, a first-in-class, off-the-shelf, platelet-rich plasma (PRP) product designed for use by veterinarians, are currently available for commercial sale.
Company Contact
John Lai, CEO
PetVivo Holdings, Inc.
Email Contact: info1@petvivo.com
Tel (952) 405-6216
Forward-Looking commercial Statements
The foregoing information regarding PetVivo Holdings, Inc. (the "Company") may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company's proposed development and commercial timelines, and can be identified by the use of words such as "may," "will," "expect," "project," "estimate," "anticipate," "plan," "believe," "potential," "should," "continue" or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the Company's business are described in detail in the Company's Annual Report on Form 10-K for the year ended March 31, 2025, and other periodic and current reports filed with the Securities and Exchange Commission. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
